ClinicalTrials.gov
public full text
Public Domain
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer
This I/II study will evaluate to see how safe and useful irreversible electroporation (also called NanoKnife) is in patients with locally advanced pancreatic cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer#804844
- Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer.#840375
- Irreversible Electroporation Ablation for Colorectal Metastases to the Lung#1033519
- Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer#886269
- Immunologic Signatures Following Surgery for Pancreatic Cancer#813893
Record · ID 1161409
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive